Literature DB >> 16706524

A concise stereoselective synthesis of Preussin, 3-epi-Preussin, and analogues.

Myra Beaudoin Bertrand1, John P Wolfe.   

Abstract

[reaction: see text] A new stereoselective synthesis of the antifungal and antitumor agents Preussin and 3-epi-Preussin via a Pd-catalyzed carboamination of a protected amino alcohol is described. The key transformation leads to simultaneous formation of the N-C2 bond and the C1'-aryl bond, and allows installation of the aryl group one step from the end of the sequence. This strategy permits the facile construction of a variety of preussin analogues bearing different aromatic groups.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16706524      PMCID: PMC2613785          DOI: 10.1021/ol0606435

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  12 in total

1.  Short-step syntheses of all stereoisomers of preussin and their bioactivities.

Authors:  Masayuki Okue; Hidenori Watanabe; Koji Kasahara; Minoru Yoshida; Sueharu Horinouchi; Takeshi Kitahara
Journal:  Biosci Biotechnol Biochem       Date:  2002-05       Impact factor: 2.043

2.  Inhibition of cyclin-dependent kinase activity and induction of apoptosis by preussin in human tumor cells.

Authors:  T V Achenbach; E P Slater; H Brummerhop; T Bach; R Müller
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

3.  Identification of preussin as a selective inhibitor for cell growth of the fission yeast ts mutants defective in Cdc2-regulatory genes.

Authors:  K Kasahara; M Yoshida; J Eishima; K Takesako; T Beppu; S Horinouchi
Journal:  J Antibiot (Tokyo)       Date:  1997-03       Impact factor: 2.649

4.  The relative and absolute stereochemistry of the antifungal agent preussin.

Authors:  J H Johnson; D W Phillipson; A D Kahle
Journal:  J Antibiot (Tokyo)       Date:  1989-07       Impact factor: 2.649

5.  L-657,398, a novel antifungal agent: fermentation, isolation, structural elucidation and biological properties.

Authors:  R E Schwartz; J Liesch; O Hensens; L Zitano; S Honeycutt; G Garrity; R A Fromtling; J Onishi; R Monaghan
Journal:  J Antibiot (Tokyo)       Date:  1988-12       Impact factor: 2.649

6.  Palladium-catalyzed tandem N-arylation/carboamination reactions for the stereoselective synthesis of N-aryl-2-benzyl pyrrolidines.

Authors:  Qifei Yang; Joshua E Ney; John P Wolfe
Journal:  Org Lett       Date:  2005-06-23       Impact factor: 6.005

7.  Selective synthesis of 5- or 6-aryl octahydrocyclopenta[b]pyrroles from a common precursor through control of competing pathways in a Pd-catalyzed reaction.

Authors:  Joshua E Ney; John P Wolfe
Journal:  J Am Chem Soc       Date:  2005-06-22       Impact factor: 15.419

8.  Structure-activity relationships of synthetic antibiotic analogues of anisomycin.

Authors:  S S Hall; D Loebenberg; D P Schumacher
Journal:  J Med Chem       Date:  1983-04       Impact factor: 7.446

9.  Palladium-catalyzed synthesis of N-aryl pyrrolidines from gamma-(N-Arylamino) alkenes: evidence for chemoselective alkene insertion into Pd--N bonds.

Authors:  Joshua E Ney; John P Wolfe
Journal:  Angew Chem Int Ed Engl       Date:  2004-07-05       Impact factor: 15.336

10.  A flexible approach to (S)-5-alkyl tetramic acid derivatives: application to the asymmetric synthesis of (+)-preussin and protected (3S,4S)-AHPPA.

Authors:  Pei-Qiang Huang; Tian-Jun Wu; Yuan-Ping Ruan
Journal:  Org Lett       Date:  2003-11-13       Impact factor: 6.005

View more
  15 in total

1.  Use of aryl chlorides as electrophiles in Pd-catalyzed alkene difunctionalization reactions.

Authors:  Brandon R Rosen; Joshua E Ney; John P Wolfe
Journal:  J Org Chem       Date:  2010-04-16       Impact factor: 4.354

2.  Palladium-catalyzed alkene carboamination reactions for the synthesis of substituted piperazines.

Authors:  Josephine S Nakhla; Danielle M Schultz; John P Wolfe
Journal:  Tetrahedron       Date:  2009-09-15       Impact factor: 2.457

3.  Two palladium-catalyzed domino reactions from one set of substrates/reagents: efficient synthesis of substituted indenes and cis-stilbenoid hydrocarbons from the same internal alkynes and hindered Grignard reagents.

Authors:  Cheng-Guo Dong; Pik Yeung; Qiao-Sheng Hu
Journal:  Org Lett       Date:  2007-01-18       Impact factor: 6.005

4.  Palladium-Catalyzed Carboetherification and Carboamination Reactions of γ-Hydroxy- and γ-Aminoalkenes for the Synthesis of Tetrahydrofurans and Pyrrolidines.

Authors:  John P Wolfe
Journal:  European J Org Chem       Date:  2007-02

5.  Mild conditions for the synthesis of functionalized pyrrolidines via Pd-catalyzed carboamination reactions.

Authors:  Myra Beaudoin Bertrand; Matthew L Leathen; John P Wolfe
Journal:  Org Lett       Date:  2007-02-01       Impact factor: 6.005

6.  Influence of hydroxylamine conformation on stereocontrol in Pd-catalyzed isoxazolidine-forming reactions.

Authors:  Georgia S Lemen; Natalie C Giampietro; Michael B Hay; John P Wolfe
Journal:  J Org Chem       Date:  2009-03-20       Impact factor: 4.354

7.  Stereoselective Synthesis of Saturated Heterocycles via Pd-Catalyzed Alkene Carboetherification and Carboamination Reactions.

Authors:  John P Wolfe
Journal:  Synlett       Date:  2006-11-13       Impact factor: 2.454

8.  A concise asymmetric synthesis of cis-2,6-disubstituted N-aryl piperazines via Pd-catalyzed carboamination reactions.

Authors:  Josephine S Nakhla; John P Wolfe
Journal:  Org Lett       Date:  2007-07-25       Impact factor: 6.005

9.  Mild conditions for Pd-catalyzed carboamination of N-protected hex-4-enylamines and 1-, 3-, and 4-substituted pent-4-enylamines. Scope, limitations, and mechanism of pyrrolidine formation.

Authors:  Myra Beaudoin Bertrand; Joshua D Neukom; John P Wolfe
Journal:  J Org Chem       Date:  2008-10-23       Impact factor: 4.354

10.  Stereoselective synthesis of imidazolidin-2-ones via Pd-catalyzed alkene carboamination. Scope and limitations.

Authors:  Jonathan A Fritz; John P Wolfe
Journal:  Tetrahedron       Date:  2008       Impact factor: 2.457

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.